<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04431440</url>
  </required_header>
  <id_info>
    <org_study_id>XXXXX</org_study_id>
    <nct_id>NCT04431440</nct_id>
  </id_info>
  <brief_title>Silver Nanoparticles in Multidrug Resistant Bacteria</brief_title>
  <official_title>Bactericidal Effect of Silver Nanoparticles on Methecillin and Vancomycin Resistant Staphylococcus. Aureus (MRSA) Isolated From Critically Ill Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Recently, silver nanoparticles (AgNPs) have been widely used in various applications as
      antimicrobial agents, anticancer, diagnostics, biomarkers, cell labels, and drug delivery
      systems for the treatment of various diseases. The present study investigated the
      bactericidal effect of AgNPs against Methecillin Resistant Staph. aureus (MRSA) and
      Vancomycin resistant Staph aureus (VRSA)
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 11, 2020</start_date>
  <completion_date type="Anticipated">July 20, 2020</completion_date>
  <primary_completion_date type="Anticipated">July 11, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>bactericidal effect of silver nanoparticles on multidrug resistant bacteria</measure>
    <time_frame>24 hours</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Multidrug Resistent Bacteria</condition>
  <arm_group>
    <arm_group_label>Methicillin resistant staphylococcus aureus</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>vancomycin resistent staphylococcus aureus</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>silver nanoparticles</intervention_name>
    <description>effect silver nanoparticles will be examined on multidrug resistant bacteria</description>
    <arm_group_label>Methicillin resistant staphylococcus aureus</arm_group_label>
    <arm_group_label>vancomycin resistent staphylococcus aureus</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        critically ill patients
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Intensive care patients

        Exclusion Criteria:

          -  none
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>elsawy, MD</last_name>
    <phone>01030072161</phone>
    <email>saeedelsawy17@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ali, MD</last_name>
    <phone>01030072161</phone>
    <email>rashaahmed7272@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Assiut university</name>
      <address>
        <city>Assiut</city>
        <zip>71111</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>rasha hamed, MD</last_name>
      <phone>0882413201</phone>
      <email>rashaahmed11@yahoo.nom</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>June 11, 2020</study_first_submitted>
  <study_first_submitted_qc>June 11, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 16, 2020</study_first_posted>
  <last_update_submitted>June 11, 2020</last_update_submitted>
  <last_update_submitted_qc>June 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 16, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Rasha Hamed</investigator_full_name>
    <investigator_title>lecturer of anaesthesia</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

